Skip to content

The influence of preoperative neoadjuvant chemotherapy on the incidence of hypotension after induction in patients with ovarian cancer

The influence of preoperative neoadjuvant chemotherapy on the incidence of hypotension after induction in patients with ovarian cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105351
Enrollment
Unknown
Registered
2025-07-02
Start date
2025-07-02
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension after anesthesia induction

Interventions

the none-post-induction hypotension group:None
the post-induction hypotension group:None

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients who were preoperatively diagnosed with "malignant ovarian tumors" and underwent surgery under general anesthesia (with or without regional nerve block) between 2019-2024; 2.Age >= 18 years; 3.Availability of extractable anesthesia records;

Exclusion criteria

Exclusion criteria: 1.Patients undergoing secondary surgery within 30 days; 2.Surgical duration = 3 consecutive time points.

Design outcomes

Primary

MeasureTime frame
Occurrence of hypotension after induction;

Secondary

MeasureTime frame
Diastolic blood pressure;Systolic blood pressure;Mean arterial pressure;Heart rate;

Countries

China

Contacts

Public ContactZhongyu Wang

The First Affiliated Hospital of Zhengzhou University

wzy781217@163.com+86 139 3716 5514

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026